对于痕性皮虫的辅助性肉毒素
Frank Mei1, Liane O Dallalzadeh1, Preston Choi1
1Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Orbit (Amsterdam, Netherlands)
|February 28, 2025
概括
毒素-A注射在皮虫患者中为痕输入提供了暂时的缓解. 这种治疗改善了眼部刺激和眼边缘位置在活跃的结膜炎.
科学领域:
- 眼科医生 眼科 眼科
- 皮肤病学 皮肤病学
背景情况:
- 皮虫可能会导致结膜的痕变化,导致输入和三病.
- 这些变化可能导致肢体干细胞缺乏和角膜损伤.
研究的目的:
- 评估肉毒素-A作为一种缓解下眼伤痕输入的治疗方法,用于患有活跃伤痕结膜炎的患者.
主要方法:
- 一个病例系列,三名患者用肉毒素A治疗下眼皮痕输入.
- 患者在活跃结膜炎阶段接受了连续注射.
主要成果:
- 所有患者都报告眼部刺激的主观改善.
- 眼边缘的位置有所改善,眼的覆盖率降低,眼的轨迹更好.
- 没有发生皮虫恶化;患者选择重复注射.
结论:
- 毒素-A是一种有效的缓解痕输入的治疗方法,当手术禁忌时.
- 它提供症状缓解,并在活跃炎症期间改善眼功能.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
648
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
648
Skeletal Muscle Relaxants: Therapeutic Uses
457
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
457
Direct-Acting Cholinergic Agonists: Therapeutic Uses
663
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
663
Depolarizing Blockers: Pharmocokinetics
300
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
300
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
383
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
383


